I guess that GTCB has covered the major world markets with its patents. In any case Biosidus still has a long way to go, so no revenues from there the next 5 years IMO.
>What are the geographical limits of GTCB's current and pending patents? If bovine milk insulin/protein is made in latin america can it be sold in the US?<